Vaccine safety forum summaries of two workshops

Detalles Bibliográficos
Autor Corporativo: Institute of Medicine (U.S.). Vaccine Safety Forum (-)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press 1997.
Edición:1st ed
Colección:Compass series (Washington, D.C.)
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820303706719
Tabla de Contenidos:
  • Vaccine Safety Forum
  • Copyright
  • Preface
  • Contents
  • Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary
  • EXECUTIVE SUMMARY
  • INTRODUCTION
  • DIFFICULTIES IN DETECTING ADVERSE EVENTS FOLLOWING VACCINATION
  • CURRENT ADVERSE EVENT DETECTION AND RESPONSE PROCEDURES
  • Vaccine Adverse Event Reporting System
  • Large Linked Databases
  • Surveillance by Vaccine Manufacturers
  • Food and Drug Administration
  • IMPROVING DETECTION OF AND RESPONSE TO ADVERSE EVENTS
  • Increasing Reporting to VAERS
  • Improving the Quality of Information in VAERS
  • Improving Vaccine Lot Information
  • Improving the Usefulness of LLDB Data
  • Clinical Trials
  • Comparison Studies
  • ADDITIONAL AREAS FOR RESEARCH
  • REFERENCES
  • WORKSHOP AGENDA
  • INSTITUTE OF MEDICINE VACCINE SAFETY FORUM
  • PARTICIPANTS
  • Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention
  • EXECUTIVE SUMMARY
  • INTRODUCTION
  • IMMUNE RESPONSE TO VACCINE ANTIGENS
  • Premature Infants
  • GENETIC FACTORS AFFECTING DEVELOPMENT OF AUTOIMMUNITY
  • RESEARCH ON IDENTIFYING POPULATIONS AT RISK FOR ADVERSE EVENTS
  • Arthritis and Rubella Vaccine
  • Anaphylaxis and Measles, Mumps, and Rubella Vaccine
  • Convulsions and DPT
  • High-Titer Measles Vaccine
  • Multiple Sclerosis or Guillain-Barre Syndrome and Vaccines
  • Multiple-Antigen Vaccination and Adverse Immune Responses
  • RESEARCH OPPORTUNITIES
  • REFERENCES
  • WORKSHOP AGENDA
  • INSTITUTE OF MEDICINE VACCINE SAFETY FORUM
  • PARTICIPANTS.